Peptide directoryBrain, hypothalamus & pituitary

Urocortin 2

The CRHR2-selective urocortin, trialled as a heart failure infusion.

Where it comes from

Made in
Hypothalamus and brainstem, heart, skeletal muscle, skin
Sent out by
Stress; in the heart and muscle, under glucocorticoids
Acts on
  • Heart muscle (contraction)
  • Arteries (dilation)
  • Muscle (glucose uptake)
  • Hypothalamus (appetite, delayed)

What it does

  • Relaxes arteries and makes the heart contract harder without raising oxygen demand much
  • Improves glucose handling in muscle
  • Suppresses appetite hours after it is given

In medicine

  • No approved medicine; in eight men with heart failure an hour of intravenous urocortin 2 raised cardiac output and ejection fraction and lowered blood pressure and vascular resistance, while urine volume fell 1
  • It is not measured in clinical practice: the mature human peptide has never been isolated, so assays rest on the sequence predicted from the gene

Beyond the body’s own use

  • Human work stopped at those short infusions, and no urocortin 2 product has entered a phase 3 trial 1
  • Gene transfer is where the work moved: one intravenous dose of AAV8 carrying urocortin 2 improved function of the failing mouse heart for months 2
  • Its glucose effect, better uptake into muscle, is an animal finding that has not been tested in people

Sources

  1. Davis et al., Urocortin 2 infusion in human heart failure, European Heart Journal 2007
  2. Lai et al., Intravenous AAV8 encoding urocortin-2 increases function of the failing heart in mice, Human Gene Therapy 2015

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.